Abstract
RNA recognition motif (RRM) is the most abundant RNA-binding domain, mainly known to involve in regulating post-transcriptional processes like intron splicing, stability and mRNA intracellular translocation. As RNA metabolism in neurons attributes a significant proportionality towards neurodegenerative diseases, potential role of RRM domains has become more conspicuous. Here, through flexible protein-protein docking and molecular dynamics simulation approaches, we postulate biochemically auspicious interactions occurring between Butyrylcholinesterase (BuChE) and RRM domains of transactive response DNA binding protein, embryonic lethal abnormal vision like protein 4 and heterogeneous nuclear ribonucleoprotein A1 protein. Through a comprehensive analysis of these interactions, we observed an exclusive binding behavior for RRM domains. Evidently, upon binding to RRMs, omega loop of BuChE attains a closed conformation and masks the access of substrate to the catalytic triad and oxyanion hole. Moreover, prominent adjustments were detected in RRM-bound BuChE at the peripheral anionic, choline binding and proton transfer sites. We propose that interaction of RNA-binding proteins to BuChE may decrease its ability to hydrolyze multiple choline esters, which may contribute in delayed progression of poor cognition during neurodegenerative disorders.
Keywords: Cholinergic molecular dynamic simulations, Neurodegeneration, neurotransmission, protein-protein docking, RNA recognition motif.
CNS & Neurological Disorders - Drug Targets
Title:Molecular Dynamics and Regulation of Butyrylcholinesterase Cholinergic Activity by RNA Binding Proteins
Volume: 13 Issue: 8
Author(s): Iqra Sohail and Sajid Rashid
Affiliation:
Keywords: Cholinergic molecular dynamic simulations, Neurodegeneration, neurotransmission, protein-protein docking, RNA recognition motif.
Abstract: RNA recognition motif (RRM) is the most abundant RNA-binding domain, mainly known to involve in regulating post-transcriptional processes like intron splicing, stability and mRNA intracellular translocation. As RNA metabolism in neurons attributes a significant proportionality towards neurodegenerative diseases, potential role of RRM domains has become more conspicuous. Here, through flexible protein-protein docking and molecular dynamics simulation approaches, we postulate biochemically auspicious interactions occurring between Butyrylcholinesterase (BuChE) and RRM domains of transactive response DNA binding protein, embryonic lethal abnormal vision like protein 4 and heterogeneous nuclear ribonucleoprotein A1 protein. Through a comprehensive analysis of these interactions, we observed an exclusive binding behavior for RRM domains. Evidently, upon binding to RRMs, omega loop of BuChE attains a closed conformation and masks the access of substrate to the catalytic triad and oxyanion hole. Moreover, prominent adjustments were detected in RRM-bound BuChE at the peripheral anionic, choline binding and proton transfer sites. We propose that interaction of RNA-binding proteins to BuChE may decrease its ability to hydrolyze multiple choline esters, which may contribute in delayed progression of poor cognition during neurodegenerative disorders.
Export Options
About this article
Cite this article as:
Sohail Iqra and Rashid Sajid, Molecular Dynamics and Regulation of Butyrylcholinesterase Cholinergic Activity by RNA Binding Proteins, CNS & Neurological Disorders - Drug Targets 2014; 13 (8) . https://dx.doi.org/10.2174/1871527313666141023144523
DOI https://dx.doi.org/10.2174/1871527313666141023144523 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Arjunolic Acid: A Promising Antioxidant Moiety with Diverse Biological Applications
Current Organic Chemistry Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Current Alzheimer Research Homology Modeling of Adenosine A2A Receptor and Molecular Docking for Exploration of Appropriate Potent Antagonists for Treatment of Parkinsons Disease
Current Aging Science Past, Present and Future Drugs for the Treatment of Obsessive- Compulsive Disorder
Current Medicinal Chemistry Mitochondrial Respiration in the Platelets of Patients with Alzheimer’s Disease
Current Alzheimer Research The Effect of Resveratrol on Neurodegenerative Disorders: Possible Protective Actions Against Autophagy, Apoptosis, Inflammation and Oxidative Stress
Current Pharmaceutical Design Pharmacological Therapy of Parkinson’s Disease: Current Options and New Avenues
Recent Patents on CNS Drug Discovery (Discontinued) Disconnection of Language and Memory in Semantic Dementia: A Comparative and Theoretical Analysis
Current Alzheimer Research Editorial [Hot Topic: Oxidative Stress Induced-Metabolic Imbalance, Mitochondrial Failure, And Cellular Hypoperfusion As Primary Pathogenetic Factors For The Development Of Alzheimer Disease Which Can Be Used As An Alternate And Successful Drug Treatment Strategy: Past, Present And Future (Guest Editor: Gjumrakch Aliev)]
CNS & Neurological Disorders - Drug Targets From the Editors Perspective: Activity, Anoxia, Angiogenesis, and Alzheimers Disease
Current Neurovascular Research Responses of Glial Cells to Stress and Glucocorticoids
Current Immunology Reviews (Discontinued) Glitazones, PPAR-γ and Neuroprotection
Mini-Reviews in Medicinal Chemistry Anti-Seizure Medications and Estradiol for Neuroprotection in Epilepsy: The 2013 Update
Recent Patents on CNS Drug Discovery (Discontinued) The Endocannabinoid System in Ageing: A New Target for Drug Development
Current Drug Targets Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases
Current Topics in Medicinal Chemistry 2-Arylindoles: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activity
Current Medicinal Chemistry Targeting Heat Shock Proteins in Tauopathies
Current Alzheimer Research Pathological Peptide Folding in Alzheimers Disease and Other Conformational Disorders
Current Medicinal Chemistry Prion Protein Misfolding
Current Molecular Medicine Riluzole Exhibits No Therapeutic Efficacy on a Transgenic Rat model of Amyotrophic Lateral Sclerosis
Current Neurovascular Research